Clinicogenetic characteristics and outcomes of children with NUP98 ‐rearranged acute myeloid leukaemia: A single‐centre cohort study of 32 cases
British Journal of Haematology · 2026-07 · 209 (1) · 172-179
DOI: 10.1111/bjh.70497 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Haematology, online erschienen am 28.04.2026. Verfasst von Zhi-Xiao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Nuclear Pore Complex Proteins, Gene Rearrangement. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Peking University People's Hospital Scientific Research Development Funds.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
NUP98 rearrangements define a high‐risk, genetically heterogeneous subtype of paediatric acute myeloid leukaemia (AML), yet comprehensive clinicogenetic and survival data remain limited. This retrospective, single‐centre study of 32 paediatric patients (2017–2025) found a median age of 8.7 years and predominance of the NUP98::NSD1 fusion (68.8%), frequently co‐mutated with FLT3 ‐ITD (50%) and WT1 (43.8%). Complete remission (CR) rates increased from 53.1% to 87.5% after first and second induction. With a median follow‐up of 41.7 months, the estimated 3‐year overall survival (OS), event‐free survival (EFS) and cumulative incidence of relapse (CIR) were 81.2% (95% confidence interval [CI], 65.9%–96.5%), 62.8% (95% CI, 43.8%–81.8%) and 28.1% (95% CI, 12.9%–45.6%), respectively; corresponding rates among the 29 transplanted patients were 79.8% (95% CI, 63.5%–96.1%), 68.7% (95% CI, 50.3%–87.1%) and 26.0% (95% CI, 11.1%–43.9%) respectively. Exploratory multivariate analysis identified failure to achieve CR after induction 2 as a risk factor for OS, WT1 mutation for relapse in the entire cohort and pretransplant minimal residual disease (MRD) positivity for relapse in the transplant subgroup. This confirms that NUP98 ‐rearranged AML necessitates intensive therapy including transplant and highlights WT1 and pretransplant MRD as key prognostic markers for risk‐adapted strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
ORCID-Profile: Zhi-Xiao Zhang
Förderung
- Peking University People's Hospital Scientific Research Development Funds
Zitieren
APA
Zhang, Z. X., Zhang, L., Lu, A. D., Zhang, L. P., Jia, Y. P., & Zeng, H. M. (2026). Clinicogenetic characteristics and outcomes of children with NUP98 ‐rearranged acute myeloid leukaemia: A single‐centre cohort study of 32 cases. British Journal of Haematology, 209(1), 172-179. https://doi.org/10.1111/bjh.70497
Vancouver
Zhang ZX, Zhang L, Lu AD, Zhang LP, Jia YP, Zeng HM. Clinicogenetic characteristics and outcomes of children with NUP98 ‐rearranged acute myeloid leukaemia: A single‐centre cohort study of 32 cases. British Journal of Haematology. 2026;209(1):172-179. doi:10.1111/bjh.70497
BibTeX
@article{Zhang2026,
author = {Zhang, Zhi-Xiao and Zhang, Lin and Lu, Ai-Dong and Zhang, Le-Ping and Jia, Yue-Ping and Zeng, Hui-Min},
title = {Clinicogenetic characteristics and outcomes of children with NUP98 ‐rearranged acute myeloid leukaemia: A single‐centre cohort study of 32 cases},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {1},
pages = {172--179},
doi = {10.1111/bjh.70497}
}
EUVIMED